Elica Inagaki
Vascular Surgery · Bellevue, WANPI 1689930380
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (38.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 51.0% of the total. Reporting peaked in 2020 at $4,068 and has fallen 53.3% since, to $1,899 in 2025.
Across 56 payments — averaging $172.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Globus Medical$1K
- W. L. Gore & Associates, Inc.$1K
- Abbott$766
- Cook Medical LLC$341
- Endologix LLC$300
- plus $754 from 8 others
What the payments were for
- Grants$3,75039%
- Travel & lodging$2,95531%
- Food & beverage$2,42225%
- Education$5095%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $4,918 |
| Globus Medical | 9 | $1,386 |
| W. L. Gore & Associates, Inc. | 8 | $1,173 |
| Abbott | 2 | $766 |
| Cook Medical LLC | 6 | $341 |
| Endologix LLC | 1 | $300 |
| Shockwave Medical, Inc | 2 | $197 |
| Inari Medical, Inc. | 3 | $183 |
| Silk Road Medical, Inc. | 3 | $159 |
| Boston Scientific | 3 | $72 |
| Bolton Medical Inc | 1 | $55 |
| Pfizer | 2 | $53 |
| Argon Medical Devices, Inc. | 1 | $18 |
| Penumbra, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$3,750
- ALIF$1,257
- Omnilink Elite vascular stent system$747
- GORE TAG Thoracic Branch Endoprosthesis$671
- GORE TAG Thoracic Endoprosthesis$310
- Torus Stent Graft System$300
- ENDOCROSS Device$300
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$178
- ENDURANT IIS$140
- Cook$127
- ROSEN$121
- ENROUTE Transcarotid Stent$115
- ENROUTE Transcarotid Neuroprotection System$115
- Abre$111
How this compares
$9,637 in reported general payments places this provider in the 70th percentile of 111 vascular surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 124 | $159,491 |
| EliquisApixaban | 133 | $142,980 |
| Rosuvastatin Calcium | 49 | $1,488 |
| Atorvastatin Calcium | 75 | $837 |
| Cilostazol | 20 | $564 |
| ClopidogrelClopidogrel Bisulfate | 14 | $218 |
| Fludrocortisone Acetate | 12 | $113 |
| Oxycodone Hcl | 21 | $88 |
| Gabapentin | 20 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $53 | $142,980133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 111 vascular surgery providers in Washington.
Other vascular surgery in Bellevue
- Kathleen GibsonBellevue$593K
- Brian FerrisBellevue$170K
- Mark OmbrellaroBellevue$12K
- Sooyeon KimBellevue$9K
- Renee MinjarezBellevue$6K
- Benjamin StarnesSeatle$666K
- Sara ZettervallSeattle$126K
- Paul HayesSeattle$83K
- Elina QuirogaSeattle$69K
- Lorena de Marco GarciaYakima$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.